European Bank for induced pluripotent Stem Cells

Induced pluripotent stem cells (iPSC) are the cornerstone of many regenerative medicine projects, and offer researchers a powerful new approach to model and study a range of diseases. The European Bank for Induced Pluripotent Stem Cells (EBiSC) was established to provide researchers across academia and the pharmaceutical industry with disease-relevant, quality-controlled, research-grade iPSC lines, data and cell services, and to promote the wider use of iPSCs with the ultimate goal of improving health. EBiSC began setting up the banking infrastructure in 2014 and distributing cell lines from March 2016 onwards. Today, there are more than 800 iPSC lines in the EBiSC catalogue, covering neurodegenerative diseases, diabetes, eye and heart diseases, muscular dystrophies, and lines from healthy control donors.